Search the hub
Showing results for tags 'Blood / blood products'.
-
News Article
Blood cancer patients in England first in world to be offered ‘Trojan horse’ drug
Patient Safety Learning posted a news article in News
Thousands of patients in England with blood cancer will become the first in the world to be offered a pioneering “Trojan horse” drug that sneaks inside cancer cells and wipes them out. In guidance published on Friday, the National Institute for Health and Care Excellence (Nice) gave the green light to belantamab mafodotin, which can halt the advance of multiple myeloma for three times as long as standard treatments. The targeted therapy, which is given as an infusion every three weeks with other cancer drugs, is a special type of antibody drug that targets and attaches to cancer cells. It has been described as a Trojan horse treatment because it works by being taken into a cancer cell and unleashing a high concentration of a lethal molecule to destroy the cell from inside. Prof Peter Johnson, NHS England’s national clinical director for cancer, said the drug would be life-changing for patients and their families. “Myeloma is an aggressive type of blood cancer, but we have seen a steady improvement in the outlook for patients over recent years as we have introduced new targeted therapies,” he said. “I am delighted that patients in England will be the first to benefit from this new treatment, which has the potential to keep cancer at bay for years longer, giving people the chance of more precious time with friends and family.” Read full story Source: The Guardian, 13 June 2025- Posted
-
- Blood / blood products
- Cancer
-
(and 2 more)
Tagged with:
-
Content Article
A year after the Infected Blood Inquiry’s final report, serious transfusion risks persist. Trusts must act now to improve safety, reduce waste, and address inequality, warns Cheng Hock Toh in this HSJ article. In May 2024, the UK Infected Blood Inquiry (IBI) published its final report into the devastating failures that led to approximately 30,000 people in the UK being infected with HIV or hepatitis C through transfused blood and blood products. This tragedy has so far claimed more than 3,000 lives. One year on, the UK government has formally accepted all 12 of the report’s recommendations, either in full or in principle. Although rigorous testing has made blood itself safer, serious risks around transfusion practice remain. The government rightly acknowledges that more must be done to prevent future harm. There are already troubling signs, and trusts and commissioners must act urgently to assess and improve the quality, safety, and equity of blood transfusion care across the system.- Posted
-
- Blood / blood products
- Patient harmed
- (and 2 more)
-
News Article
NHS seeks 200,000 more blood donors in England to avoid threat to safety
Patient Safety Learning posted a news article in News
The NHS needs to fill a shortfall of more than 200,000 blood donors in England to avoid a threat to public safety, officials have said. NHS Blood and Transplant (NHSBT) wants to hit a target of 1 million blood donors to meet growing demand as just under 800,000 people – 2% of the population in England – kept the nation’s blood stocks afloat last year. An amber alert was issued last year over supply of blood for hospitals in England, and NHSBT said more was needed to avoid a red alert, meaning supply is so low that there is a threat to public safety. NHSBT’s chief executive, Dr Jo Farrar, said: “Our stocks over the past 12 months have been challenging. If we had a million regular donors, this would help keep our stocks healthy – you’d truly be one in a million.” The service said there had been a rise in the number of people who registered to be donors in the last year, but only 24% of these had gone on to donate. The amber alert was triggered in July 2024 after a cyber-attack on London hospitals, and blood stocks have remained low ever since, officials said. NHSBT said there was a critical need for more donors who have the so-called universal blood type, O-negative, which is needed for treatment in emergencies. Read full story Source: The Guardian, 9 June 2025 -
News Article
More blood victims will die without compensation
Patient Safety Learning posted a news article in News
More victims of the infected blood scandal will die without ever receiving full compensation, a government minister has said. The paymaster general Nick Thomas-Symonds was giving evidence to a special session of the public inquiry into what's been called the worst treatment disaster in NHS history. It's thought 30,000 patients in the UK were infected with HIV or hepatitis B and C after being treated with a contaminated blood clotting product or given a blood transfusion in the 1970s and 80s. Mr Thomas-Symonds agreed it was "profoundly unsatisfactory" that just 106 final compensation awards have been paid, almost a year after a damning report into the scandal was published. "I'm never going to think this is satisfactory until everybody has received the compensation that is due," the Cabinet Office minister said. "The objective should be absolutely to pay [people] as soon as possible." A final report into the scandal, published last year, found that the disaster could largely have been avoided if different decisions had been taken by the health authorities at the time. Read full story Source: BBC News, 7 May 2025- Posted
-
- Blood / blood products
- Redress
- (and 3 more)
-
News Article
Blood test firm blamed for 'catalogue of disasters'
Patient Safety Learning posted a news article in News
An NHS provider that won a £2bn contract to deliver blood-testing services for hospitals and GPs is failing to deliver reliable results, according to medical professionals. Synnovis, a public-private partnership between the medical company Synlab and Guy's and St Thomas' and King's College hospital foundation trusts, secured the contract in 2021 to deliver pathology services for just under 200 GP surgeries across south-east London. The BBC has spoken to GPs who say incorrect and delayed blood results are a "regular concern" and that the firm's performance is causing great distress to patients. The company, which fell victim to a ransomware cyberattack in June 2024 that caused more than 1,000 NHS operations to be postponed, said the attack had "significantly reduced our capacity to process samples". Synnovis, which serves six hospitals in London, added that it had "dedicated every available resource to delivering clinically safe and largely manual interim solutions". According to more than a dozen GPs we heard from, across all of south-east London's boroughs, the severity of challenges they face under Synnovis is causing anxiety for both patients and doctors. The GPs told the BBC that the blood-test issues were leading to unnecessary hospital referrals and wasted patient appointments. In one case the BBC was told about, an elderly man who was caring for his wife with dementia needlessly spent hours in accident and emergency (A&E) due to problems with his test. One GP, who spoke to the BBC anonymously, said: "It would [previously] never cross our minds that a blood test might not be reliable. This is now an everyday concern. "The current problems with Synnovis is nothing short of a national scandal," they added. Read full story Source: BBC News, 15 April 2025- Posted
-
- Blood / blood products
- Testing
-
(and 2 more)
Tagged with:
-
News Article
Infected blood victims losing faith as inquiry hearings restart
Patient Safety Learning posted a news article in News
The infected blood inquiry is holding two more days of hearings amid concerns about the government's response on compensation, with campaigners warning they are "losing faith". It comes nearly a year after the final report was published into the scandal - said to be the biggest treatment disaster in the history of the NHS. More than 30,000 people contracted HIV and hepatitis from contaminated blood products in the 1970s and 80s – and 3,000 people have since died. Victims groups have since said the government has been slow to pay out compensation and the process was lacking transparency. Inquiry chair Sir Brian Langstaff said he had decided to act given the "gravity" of the problems expressed. And a spokesperson said it was continuing to act on the inquiry's recommendations, adding: "The victims of this scandal have suffered unspeakably." Read full story Source: BBC News, 9 April 2025- Posted
-
- Legal issue
- Investigation
- (and 4 more)
-
News Article
A cyber attack has forced a US non-profit blood donor centre to postpone appointments despite declaring blood shortages just one week earlier. New York Blood Center Enterprises announced that it had “identified suspicious activity” affecting its IT systems on on 26 January 2025. In a statement, published on 29 January, it said: “We immediately engaged third-party cybersecurity experts to investigate and confirmed that the suspicious activity is a result of a ransomware incident. “We took immediate steps to help contain the threat and are working diligently with these experts to restore our systems as quickly and as safely as possible. Law enforcement has been notified.” On 1 February and 2 February 17 blood drives were cancelled as a result of the cyber attack. The centre, which is the largest independent blood supplier in the New York City area, confirmed that although it is still accepting blood donations, “processing times may be longer than normal”. There is no estimated timetable for fully restoring its operations. The attack echoes the ransomware attack on NHS pathology provider Synnovis in June 2024, which led to NHS Blood and Transplant urgently calling for donations of O Positive and O Negative blood to boost stocks. Read full story Source: Digital Health, 3 February 2025- Posted
-
- Blood / blood products
- Organisation / service factors
- (and 3 more)
-
News Article
Just 10 of 4,000 tainted blood victims have had compensation, campaigners say
Patient Safety Learning posted a news article in News
Furious victims of the infected blood scandal have said that just 10 out of 4,000 people have received compensation under a new scheme, despite pledges from the Conservatives and Labour to sort out payments this year. Campaigners say they have been “disengaged” by the Labour government and that, by this month, just 17 people out of the thousands eligible had been invited to register for compensation. Five groups representing victims met officials dealing with claims last week, only for the meetings to end with those in attendance feeling they were being treated as a nuisance, rather than victims of a scandal from which they had suffered greatly. Andrew Evans, chair of the group Tainted Blood, who was told aged 12 that he had contracted HIV from a contaminated blood product, said: “When the infected blood inquiry published its final report, the entire community breathed a collective sigh of relief. … we dared hope, for just a moment, that our decades of battling was coming to an end, and that compensation would now be swiftly forthcoming. “With the promise that all of the infected would be paid before the end of 2024, followed swiftly in 2025 by the estates of those who have died and affected relatives in their own right, campaigners and the community hoped that the finish line was in sight, and all that remained would be a series of formalities. “Since then, we have been disengaged by the government, and the goalposts have been drastically moved to the point where now, just before Christmas, only a quarter of one per cent of the infected have been offered compensation. “Our battle, rather than ceasing, has intensified. The community, already heavily traumatised, is at breaking point. We, the campaigners, bear the burden of attempting to explain what is going on, although we have little more idea of that ourselves, and supporting thousands of devastated victims.” Read full story Source: The Guardian, 22 December 2024- Posted
-
- Blood / blood products
- Investigation
- (and 2 more)
-
Content Article
Health disparities are systemic and deeply rooted in social and economic inequities. Patients living in deprived areas, from racially minoritised communities, or facing additional challenges such as homelessness or intellectual disabilities experience worse health outcomes. These disparities are compounded by mistrust in healthcare, low health literacy, cultural barriers, and discrimination. This report focuses on patients with blood disorders and/or cancers who experience health inequalities, and therefore have worse outcomes and experiences of care than patients who don’t. We looked at how social and economic factors affect the health of people living with blood disorders and cancer. Report key findings: Patients living with cancer and/or blood disorders experience significant barriers to care including delays in diagnosis, unequal access to services, and systemic discrimination, These patients also reported challenges navigating healthcare, a lack of communication, and economic burdens such as high transportation and medication costs, Social determinants of health like inadequate housing and living in deprived areas further worsened outcomes, Participants emphasised mistrust in the healthcare system, particularly among racially minoritised and LGBTQ+ communities, and highlighted the need for better coordination, cultural sensitivity training, and localised services. The project involved a literature review on health disparities and social determinants affecting patients with cancer and blood disorders. Discussions were held with local and condition-specific charities, and we conducted focus groups and a case study interview with patients and carers. These efforts aimed to gather diverse perspectives and first-hand accounts of lived experiences.- Posted
-
- Health inequalities
- Health Disparities
- (and 7 more)
-
News Article
Ireland tackled tainted blood scandal decades ago - and it has cost €800m so far
Patient Safety Learning posted a news article in News
Ireland’s blood scandals have caused human suffering and cost the State around €800m in compensation so far. A damning inquiry report in the UK this week found that authorities there covered up the infected blood scandal after knowingly exposing victims to unacceptable risks. More than 30,000 people in the UK were infected from 1970 to 1991 by contaminated blood products and transfusions. Ireland moved decades faster to address the contamination tragedy. The tribunal set up to compensate people infected by contaminated blood transfusions or blood products in the Republic of Ireland has paid out around €800m since 1996. In Ireland a compensation tribunal, which is still sitting and will continue to do so for years to come, was set up by the government in 1995 first to compensate women infected with hepatitis C as a result of the use of contaminated human immunoglobulin anti-D. This blood product was given to women with the rhesus-positive blood type to protect future pregnancies. The Finlay inquiry in the mid 1990s looked at the rules that were broken by the then blood transfusion service in producing anti-D. The Lindsay tribunal set up in 2000 examined the contamination of Factor 8 products used by men with haemophilia which were contaminated with HIV and hepatitis C. The tribunal heard how home-produced blood clotting agent caused infection in seven haemophiliacs despite earlier claims that it was safe. Read full story Source: Irish Independent, 21 May 2024- Posted
-
- Ireland
- Blood / blood products
-
(and 2 more)
Tagged with:
-
Content Article
Black and minority ethnic patients with high blood pressure have benefited from a project which was run by two Lambeth GP practices. The project aimed to reduce the very significant difference in blood pressure control (hypertension) between Black and minority ethnic patients and white patients. The year-long project resulted in the two practices achieving some of the best outcomes ever seen in South East London for overall hypertension control, with a 12% inequality gap for blood pressure control between black and white patients completely eradicated. In addition, over 300 patients from the local community were newly diagnosed with hypertension.- Posted
-
- Blood / blood products
- Health inequalities
- (and 3 more)
-
News Article
Anger as some infected blood payouts put on hold
Patient_Safety_Learning posted a news article in News
Some victims of the infected blood scandal have been told interim compensation payments of £100,000 due to be made before Christmas have been put on hold. It is thought at least 10 bereaved families have received letters saying applications approved this month cannot now proceed until they submit new paperwork. More than 30,000 people in the UK were infected with HIV and hepatitis C after being given contaminated blood products in the 1970s and 1980s. Read full article Source: BBC online, 1 December 2024 -
Content Article
Errors associated with failures in filing, actioning and communicating blood test results can lead to delayed and missed diagnoses and patient harm. This study aimed to audit how blood tests in primary care are filed, actioned and communicated, to identify areas for patient safety improvements. What this study adds When primary care clinicians retrospectively reviewed the electronic health records of 2572 patients who had recent blood tests, around 10% disagreed with the initial clinician’s actioning of test results. Out of the 1132 patients where an action (such as ‘book an appointment’) was specified, there was evidence in the electronic health records that this did occur in 89.7% (varying between 45.2% and 100% in participating practices). In 47% of patients (n=1210) there was no evidence in the electronic health records that results had been communicated to the patient. Around 50% of participating practices who completed a follow-up questionnaire had used their benchmarked results to stimulate quality improvement (QI) activities, practice learning or educational activities. How this study might affect research, practice or policy This research demonstrates variation in the way blood test results are actioned and communicated to patients, with important patient safety implications. We have shown that using a collaborative model of research in primary care can help stimulate QI and could help widen participation in research beyond traditionally ‘research active’ general practices.- Posted
-
- Diagnosis
- Tests / investigations
- (and 3 more)
-
Content Article
This article, published in Patient Safety, includes the following sections: What is Transfusion-Associated Circulatory Overload (TACO)? Occurrence of TACO and Impact on Patients. Strategies to Mitigate the Risk of TACO. -
Content Article
Top picks: Venous thromboembolism
Patient Safety Learning posted an article in High risk areas
Blood clots, particularly deep vein thrombosis (DVT) and pulmonary embolism (PE), together venous thromboembolism (VTE), pose a significant health threat to patients. These potentially life-threatening conditions can manifest silently and without warning, making vigilance and knowledge crucial. In this Top picks, we’ve pulled together resources, blogs and reports from the hub for patients and healthcare professionals, which focus on how to recognise venous thromboembolism and how to improve patient safety. 1. Deep vein thrombosis: understanding and managing your risk In this blog, Jo Jerrome, CEO of Thrombosis UK, explains the dangers of DVT and why it is important for patients and staff to be aware of the risk factors. Jo offers advice on how we can all manage our risk of DVT. 2. HSIB - Clinical decision making: diagnosis of pulmonary embolism in emergency departments This investigation by the Healthcare Safety Investigation Branch (HSIB) explores the timely recognition and treatment of suspected pulmonary embolism in emergency departments. 3. Jenny, and why we must learn from her misdiagnosis of pulmonary embolism Jenny Edwards died in February 2022 from pulmonary embolism, following misdiagnosis. In this blog, her son Tim introduces us to Jenny, illustrating the deep loss felt following her premature passing. He talks about the care she received and argues that there were multiple points at which pulmonary embolism should have been suspected. 4. Venous thromboembolism (VTE): deep vein thrombosis and pulmonary embolism VTE is a significant cause of mortality, long-term disability and long-lasting ill-health problems – many of which are avoidable. 1 in 20 people will have a VTE at some time in their life and the risk increases with age. This NHS Resolution guide provides more information about the risks of VTE and how to spot the common signs and symptoms. 5. HSIB - The assessment of venous thromboembolism risks associated with pregnancy and the postnatal period final report This investigation by the HSIB explores the issues associated with the assessment of risk factors for venous thrombosis in pregnancy and the first six weeks after birth. 6. NHS Resolution: Working to prevent avoidable venous thromboembolism VTE is an international patient safety issue and a clinical priority for the NHS. Around half of all cases of VTE are associated with hospitalisation, with many events occurring up to 90 days after admission. It is a leading and preventable cause of death in an estimated 25,000 of hospitalised patients each year. This information leaflet highlights the cost of VTE claims and what you can do in your organisation to prevent VTE. 7. Pulmonary embolism misdiagnosis – a systemic problem Tim Edwards is a risk management expert and son of Jenny, who passed away in February 2022 from pulmonary embolism, following a misdiagnosis. Frustrated by the quality of the initial investigation that followed her death and the lack of assurance that learning would take place, Tim conducted an independent review. In this opinion piece, Tim draws on his research to highlight the key patient safety issues, and to encourage further dialogue around the topic. 8. Let's Talk Clots! Help reduce your risk of DVT and PE in hospital with this simple app Download the free Let’s Talk Clots patient information app from Thrombosis UK, and help reduce your risk of DVT and pulmonary embolism in hospital. 9. Patient Safety Spotlight Interview with Beverley Hunt, Professor of Thrombosis and Haemostasis and founder of Thrombosis UK In this interview, Beverley Hunt talks about setting up Thrombosis UK and how it has grown to have a national impact on patient safety in hospitals. She also describes the value of combining policy work with seeing patients face-to-face, and explores the need to find new ways of working to deal with the pressures facing the healthcare system. 10. Risk assessment models for venous thromboembolism in medical inpatients This cohort study in JAMA Network Open aimed to determine the prognostic performance of the simplified Geneva score and other validated risk assessment models (RAMs) to predict VTE in medical inpatients. The study provided a head-to-head comparison of validated RAMs among 1352 medical inpatients. It found that sensitivity of RAMs to predict 90-day VTE ranged from 39.3% to 82.1% and specificity of RAMs ranged from 34.3% to 70.4%. The authors concluded that the clinical usefulness of existing RAMs is questionable, highlighting the need for more accurate VTE prediction strategies. 11. HSIB: Investigation into management of venous thromboembolism risk in patients following thrombolysis for an acute stroke This HSIB investigation focused on the management of VTE risk in inpatients following thrombolysis for an acute stroke detection of medical problems (that impact on VTE risk) occurring in inpatients following thrombolysis for an acute stroke. Do you have a resource or story to share? We’d love to hear about it - leave a comment below or join the hub to share your own post.- Posted
-
- Deep vein thrombosis
- Blood / blood products
- (and 4 more)
-
Content Article
Patient for Patient Safety India and National Thalassemia Welfare Society in collaboration with World Patients Alliance (WPA) and Global Action Network for Sickle Cell and Other Inherited Blood Disorders (GANSID) organised a webinar on Friday 20 Sep 2024 to mark World Patient Safety Day (WPSD). Since the theme of WPSD 2024 was focused on diagnostic errors, the webinar was on diagnostic errors in blood disorders thalassemia, sickle cell anaemia and haemophilia. Read the summary of the webinar attached.- Posted
-
- Blood / blood products
- Sickle cell
-
(and 3 more)
Tagged with:
-
Content Article
Guidelines for blood pressure (BP) measurement recommend arm support on a desk with the midcuff positioned at heart level. Still, nonstandard positions are used in clinical practice (eg, with arm resting on the lap or unsupported on the side). This study looked at the effect of commonly used arm positions on blood pressure (BP) measurements compared to the standard, recommended position. It found that commonly used, nonstandard arm positions during BP measurements substantially overestimate BP, highlighting the need for standardised positioning.- Posted
-
- Blood / blood products
- Diagnostic error
-
(and 2 more)
Tagged with:
-
Content Article
The stress and anxiety felt by patients awaiting a potential cancer diagnosis can be made much worse if they are told their sample has been lost. Delays can impact treatment options and patient outcomes. Dil Rathore is a Biomedical Scientist and Pathology Innovation Lead at Leeds Teaching Hospitals NHS Trust. In this interview, he tells us about a new tracking system he’s developed to reduce the number of patient tissue samples going missing. Can you tell us more about the histopathology service you work with? Our histopathology service focuses on diagnosing diseases by examining tissue samples under a microscope. It is key in identifying conditions like cancer, infections and inflammation. Typically collected through biopsies or surgeries, samples are processed in various ways and we then assess the tissue’s cellular structure to detect abnormalities. Our findings guide clinical decisions, such as confirming cancer types, grading tumours and determining treatment options. The detailed reports produced by our service are essential in shaping patient care and are often discussed within multidisciplinary teams for comprehensive treatment planning. Are lost samples a problem? The stress and anxiety felt by patients awaiting a potential cancer diagnosis can be made much worse if they are told their sample has been misplaced or lost. Unfortunately, this ‘never event’ happens more often than is acceptable across the NHS and globally. While working in histopathology, I became interested in clinical systems, digital pathology and sample tracking systems. These systems are used by most NHS organisations, but they are prone to user error and are inherently flawed. They can only provide historical information about a sample's past, rather than its current location, which leads to uncertainty about where these precious patient samples are at any given time. Tissue blocks move constantly around the department to undergo additional processes. Dynamic movement around the department is both a necessity and also adds to the challenge of locating these samples. How does your new system work? From developing an understanding of sample tracking systems, I identified significant opportunities to enhance patient safety. Improvements were clearly necessary, but the technology to enable change still needed to be created. So, with support from the Innovation Pop-Up* I developed a new system. Our new system allows continuous, real-time tracking of the cassettes through Radio Frequency Identification (RFID) technology. Key elements It tells us the precise location of each sample and its movement through our histopathology department. Our custom tag provides the read ranges we require for the technology to work successfully in a clinical environment. Installing antennas and readers throughout the department allowed us to collect live data on the movements of our patients' samples. Our tag provides improved signal ranges, readability, and resilience of RFID technology in harsh processing conditions. How was this work resourced and developed? Thanks to seed funding provided by the Leeds Hospitals Charity, we were able to demonstrate ‘proof of concept’ with the innovation. Demonstrating the technological capabilities of the concept helped support an additional funding application to Innovate UK’s Knowledge Asset funding, which allowed us to scale the system as a minimal viable produce (MVP). Without support and funding, we wouldn’t have been able to develop the UK's first real-time histopathology sample tracking system. Were there challenges along the way? Innovating within the NHS has historically been difficult as the required infrastructure and support mechanisms have yet to be in place. Testing a new and/or unknown technology brings uncertainty and risk. Thanks to the support of Leeds Hospitals Charity, our Innovation Pop-Up team and the Pathology departments, we have begun to understand this process more robustly and agilely. This has led to the establishment of new methods for future innovation endeavours to allow more streamlined processes to test, and potentially adopt, innovations and new ideas. What’s next for this work? Although we are still testing and validating the data, we have seen some notable improvements since using the system: The RFID real-time tracking system offers never-before-seen visibility and data on our processes, ensuring samples are accounted for from collection to testing. This can reduce the risk of human error, leading to a more rapid turnaround of results and better patient outcomes. Pathologists' workflow can be streamlined as our labs can process samples and generate reports faster, thus optimising pathologist time, allowing for quicker decision-making and treatment initiation. The impact on patient care has been incredible. Diagnostic results are being delivered quickly, helping healthcare providers make prompt decisions regarding treatment plans, leading to improved patient outcomes and quicker recoveries. What advice would you give others wanting to develop innovations in the NHS? Carrying out due diligence and discovery is vital. Knowing what technology already exists and what current market offerings are available will begin to help shape innovation. Once you understand what you would like to see, explore current offerings to investigate if simple modifications could provide the solution. If this cannot be done, work in collaboration with other departments within your Trust (Scan4Safety, Clinical Engineering, etc.) to seek a solution. What’s next for this work? We will continue to collect data on the systems' performance and expand into other areas of the Trust to enhance the data. Once we have enough data, we hope to publish our findings. We are also exploring potential partnerships to help support the commercialisation of this innovation. If you are interested in RFID or RFID for Pathology Services, please contact Dil Singh Rathore ([email protected]), Pathology Technology & Innovation Lead, Leeds Teaching Hospitals NHS Trust. *a support programme at Leeds Teaching Hospitals NHS Trust for clinicians and entrepreneurs with ideas for new products and services that solve healthcare challenges. Share your insights and innovations Have you been been involved in rolling out a new way of working that has had a positive impact on patient safety? Could you share your approach and what you have learnt along the way? To find out how you can share your insights via the hub, get in touch with the editorial team at [email protected] or find out how to submit a blog here.- Posted
-
- Innovation
- Blood / blood products
-
(and 2 more)
Tagged with:
-
Content Article
Delays in the detection or treatment of postpartum haemorrhage can result in complications or death. A blood-collection drape can help provide objective, accurate, and early diagnosis of postpartum haemorrhage, and delayed or inconsistent use of effective interventions may be able to be addressed by a treatment bundle. Authors of this study, published in the New England Journal of Medicine, conducted an international, cluster-randomized trial to assess a multicomponent clinical intervention for postpartum haemorrhage in patients having vaginal delivery. The intervention included a calibrated blood-collection drape for early detection of postpartum haemorrhage and a bundle of first-response treatments (uterine massage, oxytocic drugs, tranexamic acid, intravenous fluids, examination, and escalation), supported by an implementation strategy (intervention group). -
Content Article
Postpartum haemorrhage is a leading cause of maternal deaths. Now a new study points to a surprisingly simple and inexpensive solution. If the woman lies on a plastic sheet with a small transparent pouch at the other end to collect the blood, the medical team has an immediate sense of how much danger she's in and can take swift action. Read the full article, published by NPR, via the link below. -
Content Article
On Nov 7 2023, NHS Resolution’s Safety and Learning team, hosted a virtual forum on learning from venous thromboembolism (VTE) claims in primary care. The purpose was to raise awareness of the cost and scale of harm, discuss the challenges and recommendations around recognition and treatment of VTE in general practice. We heard from a range of experts in the field with experience in developing and spreading best practice.- Posted
-
- GP
- Primary care
-
(and 3 more)
Tagged with:
-
News Article
Blood-inquiry families heckle PM over compensation
Patient Safety Learning posted a news article in News
Rishi Sunak says the government will wait for the Infected Blood Inquiry's final report before responding to questions around victim compensation. Bereaved families heckled the prime minister when he told the inquiry the government would act as "quickly as possible". Mr Sunak told the inquiry people infected and affected by the scandal had "suffered for decades" and he wanted a resolution to "this appalling tragedy". But although policy work was progressing and the government in a position to move quickly, the work had "not been concluded". He indicated there was a range of complicated issues to work through. "If it was a simple matter, no-one would have called for an inquiry," Mr Sunak said. Campaign group Factor 8 said Mr Sunak had offered "neither new information not commitments" to the victims and bereaved families, which felt "like a betrayal". Haemophilia Society chief executive Kate Burt said: "This final delay is demeaning, insulting and immensely damaging. "We urge the prime minister to find the will to do the right thing and finally deliver compensation which recognises the suffering that has been caused." Read full story Source: BBC News, 26 July 2023- Posted
-
- Blood / blood products
- Redress
- (and 4 more)
-
Content Article
Did you know venous thromboembolism (VTE), is an umbrella term for deep vein thrombosis and pulmonary embolism? VTE is a significant cause of mortality, long-term disability and long-lasting ill-health problems – many of which are avoidable. 1 in 20 people will have a VTE at some time in their life and the risk increases with age. This NHS Resolution guide provides more information about the risks of VTE and how to spot the common signs and symptoms. Read the guide via the link below -
Content Article
Central line–associated bloodstream infections (CLABSI) account for many harms suffered in healthcare and are associated with increased costs and disease burden. Central line rounds, like medical rounds, are a multidisciplinary bedside assessment strategy for all active central lines on a unit. The project team designed a HIPAA-protected, text-based process for assessing central lines for risk factors contributing to infection. Staff initiated a consultation via a virtual platform with an interdisciplinary team composed of oncology and infectious disease experts. The virtual discussion included recommendations for a line-related plan of care.- Posted
-
- Healthcare associated infection
- Blood / blood products
- (and 5 more)